Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Soins Gerontol ; 27(154): 23-27, 2022.
Article in French | MEDLINE | ID: mdl-35393032

ABSTRACT

Rectal cancer is a common disease of the elderly. Current treatment recommendations are established for young subjects in good general health condition, without taking into account the frailty, comorbidities and polymedications inherent in patients over 75 years old. For locally advanced lower and middle rectal cancers (T3, T4 or N+), these are based on variations of regimens including neoadjuvant chemoradiotherapy, surgery of the rectum with total removal of the mesorectum, and a possibility of adjuvant chemotherapy. This restrictive treatment presents a problem of compliance and is not without adverse effects. Treatment by short exclusive radiotherapy or chemoradiotherapy with close monitoring according to the Watch and Wait strategy can be proposed to fragile patients not eligible for surgery, even if there is a non-negligible risk of recurrence.


Subject(s)
Rectal Neoplasms , Aged , Chemoradiotherapy , Humans , Neoadjuvant Therapy , Neoplasm Recurrence, Local , Rectal Neoplasms/radiotherapy , Rectum/surgery , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...